Sarcoma  >>  Ixempra (ixabepilone)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ixempra (ixabepilone) / Otsuka, R-Pharm, Allarity Therap
NCT00030108: Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Completed
1
30
US
ixabepilone
National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI)
Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Kidney Cancer, Leukemia, Liver Cancer, Neuroblastoma, Ovarian Cancer, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
03/10
04/10
NCT01012362: Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Checkmark Data-AACR
Mar 2012 - Mar 2012: Data-AACR
Terminated
1
31
US
Pazopanib, Pazopanib hydrochloride, GW786034B, Ixabepilone, IXEMPRA(TM)
Masonic Cancer Center, University of Minnesota, GlaxoSmithKline
Breast Cancer, Lung Cancer, Colon Cancer, Pancreatic Cancer, Head and Neck Cancer, Kidney Cancer, Sarcoma, Hepatocellular Cancer
02/13
02/13
NCT01454479: A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma

Unknown status
1
24
NA
Lapatinib and ixempra, Lapatinib, Ixempra
Hung-Hsueh Chou, GlaxoSmithKline, Bristol-Myers Squibb
Recurrent Endometrial Cancer
04/13
04/14

Download Options